(Q37483486)

20 August 2017

1 reference

title

Microvascular lesions of diabetic retinopathy: clues towards understanding pathogenesis? (English)

1 reference

20 August 2017

0 references

0 references

1 reference

T M Curtis

1

1 reference

20 August 2017

T A Gardiner

series ordinal

2

1 reference

20 August 2017

A W Stitt

series ordinal

3

1 reference

20 August 2017

15 May 2009

1 reference

20 August 2017

1 reference

20 August 2017

23

1 reference

20 August 2017

7

1 reference

20 August 2017

1496-1508

1 reference

https://scigraph.springernature.com/pub.10.1038/eye.2009.108

20 August 2017

0 references

cites work

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Diabetic retinopathy: seeing beyond glucose-induced microvascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Oscillatory potential analysis and ERGs of normal and diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Visual dysfunction, neurodegenerative diseases, and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Death of retinal neurons in streptozotocin-induced diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Retinal glial cell immunoreactivity and neuronal cell changes in rats with STZ-induced diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Diabetes alters osmotic swelling characteristics and membrane conductance of glial cells in rat retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Arteriolar involvement in the microvascular lesions of diabetic retinopathy: implications for pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Regulatory mechanisms in the retinal and choroidal circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

The retinal blood flow in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Retinal arteriolar narrowing and risk of diabetes mellitus in middle-aged persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Vascular endothelial growth factor and severity of nonproliferative diabetic retinopathy mediate retinal hemodynamics in vivo: a potential role for vascular endothelial growth factor in the progression of nonproliferative diabetic retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Retinal blood flow in diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Retinal circulation times in diabetes mellitus type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Retinal haemodynamics in individuals with well-controlled type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Retinal blood flow in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

The role of lipids and protein kinase Cs in the pathogenesis of diabetic retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Antioxidants attenuate early up regulation of retinal vascular endothelial growth factor in streptozotocin-diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Role of mitochondrial superoxide dismutase in the development of diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Possible pathophysiological mechanisms for diabetic angiopathy in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Ocular blood flow and associated functional deviations in diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Angiotensin II receptor blockers and angiotensin converting enzyme inhibitors: implication of radical scavenging and transition metal chelation in inhibition of advanced glycation end product formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Protein kinase C activation and the development of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Inhibition of PKC beta by oral administration of ruboxistaurin is well tolerated and ameliorates diabetes-induced retinal hemodynamic abnormalities in patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Effect of ruboxistaurin on the visual acuity decline associated with long-standing diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Cellular physiology of retinal and choroidal arteriolar smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Diabetes downregulates large-conductance Ca2+-activated potassium beta 1 channel subunit in retinal arteriolar smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Diabetic retinopathy: early functional changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Partial reversal of protan and tritan colour defects with inhaled oxygen in insulin dependent diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Hyperoxia improves contrast sensitivity in early diabetic retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Leukocyte-mediated endothelial cell injury and death in the diabetic retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Retinal arteriolar caliber predicts incident retinopathy: the Australian Diabetes, Obesity and Lifestyle (AusDiab) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Noninvasive evaluation of wall shear stress on retinal microcirculation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Diabetic retinopathy: quantitative variation in capillary basement membrane thickening in arterial or venous environments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Endothelial/pericyte interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Ischemic vascular damage can be repaired by healthy, but not diabetic, endothelial progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Advanced glycation of fibronectin impairs vascular repair by endothelial progenitor cells: implications for vasodegeneration in diabetic retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Histological and ultrastructural investigation of retinal microaneurysm development in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Vascular lesions in diabetes are distributed non-uniformly within the retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Arteriolar involvement in diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Regional retinal blood flow and vascular autoregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Diabetic macular oedema: a clinical overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Experimental diabetes causes breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Inhibition of advanced glycation and absence of galectin-3 prevent blood-retinal barrier dysfunction during short-term diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Retinal vessel dilatation and elongation precedes diabetic macular oedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

Endogenous VEGF is required for visual function: evidence for a survival role on müller cells and photoreceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

The Wisconsin epidemiological study of diabetic retinopathy: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

7 January 2021

Seeing beyond retinopathy in diabetes: electrophysiological and psychophysical abnormalities and alterations in vision

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

7 January 2021

Alterations in the retinal dopaminergic neuronal system in rats with streptozotocin-induced diabetes

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

7 January 2021

Neuronal and microglial response in the retina of streptozotocin-induced diabetic rats

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

7 January 2021

Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

7 January 2021

Diameters of the Retinal Vessels in Diabetic and Normal Subjects

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

7 January 2021

Evaluating retinal circulation using video fluorescein angiography in control and diabetic rats

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

7 January 2021

Prevention of hemodynamic and vascular albumin filtration changes in diabetic rats by aldose reductase inhibitors.

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

7 January 2021

Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

7 January 2021

Binding of monocytes from normolipidemic hyperglycemic patients with type 1 diabetes to endothelial cells is increased in vitro

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

7 January 2021

Retinal Blood Flow Alterations During Progression of Diabetic Retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

7 January 2021

Retinal vasoconstriction after laser treatment for diabetic macular edema.

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

7 January 2021

Retinal vascular patterns. IV. Diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

7 January 2021

Advanced glycation end products and diabetic complications

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

7 January 2021

Diabetic glycemic control and retinal blood flow

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

7 January 2021

Replicative senescence and cell death

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

7 January 2021

Fluid shear stress stimulates phosphorylation of Akt in human endothelial cells: involvement in suppression of apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

7 January 2021

The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

7 January 2021

Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

7 January 2021

Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

7 January 2021

Diabetic macular edema: risk factors and concomitants

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

7 January 2021

The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

7 January 2021

The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.108

7 January 2021

Identifiers

DOI

10.1038/EYE.2009.108

1 reference

Dimensions Publication ID

20 August 2017

0 references

1 reference